Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor TherapyNeoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasmRecruitingPhase 22026-01-23NCT05283226

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
NATCO Pharma Ltd.1

13 results · Page 1 of 1

Swipe the table sideways for more columns.